Drug Targets Flashcards
Pharmacodynamics
The physiological effect that a drug has on the body
Pharmacokinetics
The metabolism of a drug by the body
What are drugs?
A drug is a molecule that is applied to a physiological system to alleviate symptoms
Edible/ natural components are NOT drugs
Therapy
A therapy treats the cause of a condition to alleviate symptoms, but it does not rectify the underlying physiological cause of the disease
Cure
A cure removes the underlying cause of a disease
Drug development process
The drug discovery process can take around 15 years
- A chemist synthesises a variety of molecules specific to a receptor
- Lead optimisation chooses the best of these molecules based on the efficacy and interaction of the drug in cell lines
- Pre-phase I studies examine the pharmacokinetics in animal models
- Clinical trails phases I-III progress the drug into humans
- FDA approval
Drug targets
Drugs can bind to biological molecules such as lipids, nucleic acids and proteins
The majority of drugs bind to proteins, specifically receptors
Ion channel coupled receptors
Quaternary proteins (5-7 subunits)
When a ligand binds to the receptor it causes a conformational change, opening the channel
The molecule/ion allowed through the pore is dependent on size and charge
GPCRs
GPCRs are very common drug targets
Single polypeptide with 7 transmembrane domains
The cytosolic side is associated with a G protein
The G protein fully associates with the receptor when a ligand activates the receptor, this leads to downstream signalling via secondary messenger systems
Enzyme coupled receptors
Transmembrane proteins with a cytosolic side (kinase domain) and extracellular side (ligand-binding site)
Exist a monomers but the binding of a ligand causes dimerisation
Nuclear receptors
Exist in the cytosol bound to a repressor protein
Binding of the ligand displaces the repressor and the complex is translocated to the nucleus, where it can interact with DNA to influence gene expression
Agonist
Binds to and activates receptors
Antagonist
Binds to receptors, having no effect
Sometimes called blockers
Inverse agonist
Binds to receptors and causes an action opposite of the normal function of that receptor
Blocker
Binds to ion channels and blocks movement of ions through the pore